Goldman Sachs
-
China Resources Pharmaceutical Group priced its Hong Kong IPO near the middle of expectations on Friday morning, raising HK$14bn ($1.8bn) after investors stormed into the trade. -
-
World Bank has reopened the 10 year part of the dollar curve, with other public sector issuers keen to follow it into the tenor.
-
-
-
US banks reporting earnings in the third quarter ubiquitously saw steep upturns in revenues from fixed income trading, despite some seeing overall falls in year over year revenues, as divergences of opinion on the Federal Reserve’s plans for interest rates caused increased trading in bonds.
-
The long end will stay very much in vogue for euro issuers next week — which SSA bankers are predicting could be the last big window of issuance for the year.
-
In a troubled new issue market strewn with casualties, the $1.8bn-plus IPO of ConvaTec, the UK medical supplies maker, got covered at its base size on Tuesday, while Misys, the London-based banking software producer, opened the books for its £650m-£750m IPO with a lower free float than initially planned.
-
Goldman Sachs showed Europe’s investors were comfortable with callable senior bonds this week, laying the grounds for more US — and eventually European — banks to follow into the total loss absorbing capacity (TLAC) friendly structure.
-
-
Dis-Chem Pharmacies, one of the leading South African pharmacy chains, is preparing an IPO on the Johannesburg Stock Exchange to raise funds to expand its operations and reduce its debt.
-
Goldman Sachs raised €1.25bn in callable senior debt on Thursday, showing other US banks that European accounts are comfortable investing in the total loss absorbing capacity (TLAC) friendly asset class.
